News

24X Bermuda Achieves Historic FX NDF Trading Milestone

24X Bermuda Achieves Historic FX NDF Trading Milestone

24X Bermuda Achieves Remarkable Trading Volume

24X Bermuda Limited has reached an unprecedented milestone in the foreign exchange (FX) market, recording a daily trading volume of $9 billion for non-deliverable forwards (NDFs). This significant achievement occurred recently, demonstrating the upward trajectory of the company’s trading platform. The surge in trading volume reflects the robust engagement of institutional users globally.

CEO's Insights on Growth and Future Plans

Dmitri Galinov, the CEO and Founder of 24X, expressed his enthusiasm regarding this record performance. His remarks highlighted the increasing preference among institutional clients for the intuitive and highly efficient platform offered by 24X. 'This new record is a demonstration of our continued momentum as our global institutional users increasingly turn to our robust platform for their FX trading activity,' he stated.

Galinoov further elaborated that the firm’s growth trajectory is not merely a statistic but indicative of the substantial value the platform offers. With continuous investment in product development and enhancements, he anticipates that trading activity will further escalate as new products are introduced over the coming months.

Comprehensive Trading Solutions

In addition to their NDF offerings, 24X provides a range of trading solutions, including Deliverable Swaps, Non-Deliverable Swaps, and Spot trading. These services cater specifically to the needs of institutional customers, ensuring that they have access to a diverse set of trading instruments. Since its inception in 2019, 24X has distinguished itself in the market by providing a multi-asset trading interface that allows users to achieve lower costs while accessing more substantial liquidity.

About 24X Bermuda Limited

24X Bermuda Holdings LLC operates as a key player in the financial services landscape, comprising two main subsidiaries. The first, 24X Bermuda Limited, facilitates seamless currency exchanges, while the second, 24X National Exchange LLC, is notable for being one of the first national securities exchanges approved by the SEC, operating extended hours to meet global demand. The mission of 24X centers on offering cost-effective trading solutions across various asset classes around the clock.

The company is dedicated to lowering trading costs in the global markets and innovating workflows tailored uniquely to each asset class. As it continues to gain traction in the marketplace, 24X aims to enhance the trading experience for all its clients.

Contacting 24X Bermuda Limited

For inquiries, 24X offers straightforward communication channels. For any media-related inquiries or further information regarding their groundbreaking services, interested parties can reach out to their dedicated public relations representative, Eric Andrus.

Frequently Asked Questions

What does 24X Bermuda Limited specialize in?

24X specializes in providing innovative trading solutions in the foreign exchange market, particularly focusing on non-deliverable forwards, swaps, and spot trading.

When did 24X reach its record trading volume?

The record trading volume of $9 billion was achieved recently, marking a significant milestone for the company.

Who is the CEO of 24X Bermuda Limited?

Dmitri Galinov serves as the CEO and Founder of 24X Bermuda Limited.

What services does 24X offer aside from NDFs?

In addition to NDFs, 24X also provides Deliverable Swaps, Non-Deliverable Swaps, and Spot trading services.

How can I contact 24X for more information?

Interested individuals can contact Eric Andrus for media inquiries and further information about 24X's services.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 11

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Secures $300 Million Loan for Growth

Updated Category News Views 255

America's Car-Mart Secures Funding for Future Growth America's Car-Mart, Inc. (NASDAQ: CRMT), a leading automotive retailer, has taken a strategic step by closing a significant five-year, $300 million term loan. This loan, managed by the seasoned professionals at Silver Point Capital, L.P., aims to enhance the company’s capital structure and support its long-term growth...

Continue Reading
IASO Bio's Breakthrough Drug Application Acceptance in Singapore

Updated Category News Views 251

IASO Bio’s Major Step Forward with New Drug Application IASO Biotherapeutics, a pioneering biopharmaceutical company dedicated to the advancement of innovative cell therapies and biologics, has reached a significant milestone. The Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel, known as...

Continue Reading
Creating Community Leaders: National Heritage Academies and United Way

Updated Category News Views 150

Empowering Students to Make a Difference The student-led organization is providing career opportunities while connecting with the community. National Heritage Academies® (NHA) is thrilled to celebrate its collaboration with United Way through the Student United Way program. This initiative equips high school students with essential tools and opportunities to enact...

Continue Reading
Future Growth of Augmented and Virtual Reality Technologies

Updated Category News Views 259

Exploring the Growth of Augmented Reality and Virtual Reality Market The global market for Augmented Reality (AR) and Virtual Reality (VR) is on the rise, with expectations of substantial growth over the next few years. Analysts estimate that this sector will expand by approximately USD 442.99 billion between 2024 and 2028. The compound annual growth rate (CAGR) for this...

Continue Reading
ImmVira Launches Innovative Exosome, Transforming Cosmetics

Updated Category News Views 407

ImmVira Leads the Way with Groundbreaking Exosome Technology In a remarkable advancement for the cosmetic industry, ImmVira Group has announced its innovative product, MVR-EX103, an engineered exosome specifically developed for treating superficial skin depressions. This development marks a pivotal moment, as it has successfully acquired the International Nomenclature...

Continue Reading